Generation Bio (NASDAQ: GBIO) is a biotechnology company dedicated to revolutionizing gene therapy with its innovative non-viral gene delivery platform. Founded in 2016, Generation Bio aims to develop a new class of genetic medicines that can offer long-lasting, scalable, and affordable treatments for patients with genetic diseases. By leveraging its cutting-edge technology, Generation Bio is poised to transform the field of gene therapy and improve outcomes for patients worldwide.

Refer new talent to Generation Bio